_version_ 1784779635564740608
author Serrano-Gonzalo, I.
López de Frutos, L.
Arévalo-Vargas, I.
Fernández-Galán, M. Á.
Morales-Conejo, M.
Calle-Gordo, M. V.
Vitoria-Miñana, I.
Correcher-Medina, P.
Madinaveitia-Ochoa, A.
Hernández-Rivas, J. Á.
García-Frade, J.
Ibarretxe-Gerediaga, D.
Delgado-Mateos, F.
Tormo-Díaz, M. D. M.
Ruíz-Guinaldo, M. Á.
Mora-Casterá, E.
Noya-Pereira, M. S.
Albarracín-Arraigosa, A.
López-Dupla, M.
Balanzat-Muñoz, J.
Lozano-Almela, M. L.
Labbadia, F.
Andrade-Campos, M.
Giraldo, P.
author_facet Serrano-Gonzalo, I.
López de Frutos, L.
Arévalo-Vargas, I.
Fernández-Galán, M. Á.
Morales-Conejo, M.
Calle-Gordo, M. V.
Vitoria-Miñana, I.
Correcher-Medina, P.
Madinaveitia-Ochoa, A.
Hernández-Rivas, J. Á.
García-Frade, J.
Ibarretxe-Gerediaga, D.
Delgado-Mateos, F.
Tormo-Díaz, M. D. M.
Ruíz-Guinaldo, M. Á.
Mora-Casterá, E.
Noya-Pereira, M. S.
Albarracín-Arraigosa, A.
López-Dupla, M.
Balanzat-Muñoz, J.
Lozano-Almela, M. L.
Labbadia, F.
Andrade-Campos, M.
Giraldo, P.
author_sort Serrano-Gonzalo, I.
collection PubMed
description
format Online
Article
Text
id pubmed-9430037
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94300372022-08-31 P1541: PRELIMINARY RESULTS OF TWO YEARS FOLLOW-UP OF TYPE 1 GAUCHER DISEASE PATIENTS TREATED WITH ELIGLUSTAT IN TRAZELGA PROJECT. Serrano-Gonzalo, I. López de Frutos, L. Arévalo-Vargas, I. Fernández-Galán, M. Á. Morales-Conejo, M. Calle-Gordo, M. V. Vitoria-Miñana, I. Correcher-Medina, P. Madinaveitia-Ochoa, A. Hernández-Rivas, J. Á. García-Frade, J. Ibarretxe-Gerediaga, D. Delgado-Mateos, F. Tormo-Díaz, M. D. M. Ruíz-Guinaldo, M. Á. Mora-Casterá, E. Noya-Pereira, M. S. Albarracín-Arraigosa, A. López-Dupla, M. Balanzat-Muñoz, J. Lozano-Almela, M. L. Labbadia, F. Andrade-Campos, M. Giraldo, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430037/ http://dx.doi.org/10.1097/01.HS9.0000849020.51692.b3 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Serrano-Gonzalo, I.
López de Frutos, L.
Arévalo-Vargas, I.
Fernández-Galán, M. Á.
Morales-Conejo, M.
Calle-Gordo, M. V.
Vitoria-Miñana, I.
Correcher-Medina, P.
Madinaveitia-Ochoa, A.
Hernández-Rivas, J. Á.
García-Frade, J.
Ibarretxe-Gerediaga, D.
Delgado-Mateos, F.
Tormo-Díaz, M. D. M.
Ruíz-Guinaldo, M. Á.
Mora-Casterá, E.
Noya-Pereira, M. S.
Albarracín-Arraigosa, A.
López-Dupla, M.
Balanzat-Muñoz, J.
Lozano-Almela, M. L.
Labbadia, F.
Andrade-Campos, M.
Giraldo, P.
P1541: PRELIMINARY RESULTS OF TWO YEARS FOLLOW-UP OF TYPE 1 GAUCHER DISEASE PATIENTS TREATED WITH ELIGLUSTAT IN TRAZELGA PROJECT.
title P1541: PRELIMINARY RESULTS OF TWO YEARS FOLLOW-UP OF TYPE 1 GAUCHER DISEASE PATIENTS TREATED WITH ELIGLUSTAT IN TRAZELGA PROJECT.
title_full P1541: PRELIMINARY RESULTS OF TWO YEARS FOLLOW-UP OF TYPE 1 GAUCHER DISEASE PATIENTS TREATED WITH ELIGLUSTAT IN TRAZELGA PROJECT.
title_fullStr P1541: PRELIMINARY RESULTS OF TWO YEARS FOLLOW-UP OF TYPE 1 GAUCHER DISEASE PATIENTS TREATED WITH ELIGLUSTAT IN TRAZELGA PROJECT.
title_full_unstemmed P1541: PRELIMINARY RESULTS OF TWO YEARS FOLLOW-UP OF TYPE 1 GAUCHER DISEASE PATIENTS TREATED WITH ELIGLUSTAT IN TRAZELGA PROJECT.
title_short P1541: PRELIMINARY RESULTS OF TWO YEARS FOLLOW-UP OF TYPE 1 GAUCHER DISEASE PATIENTS TREATED WITH ELIGLUSTAT IN TRAZELGA PROJECT.
title_sort p1541: preliminary results of two years follow-up of type 1 gaucher disease patients treated with eliglustat in trazelga project.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430037/
http://dx.doi.org/10.1097/01.HS9.0000849020.51692.b3
work_keys_str_mv AT serranogonzaloi p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT lopezdefrutosl p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT arevalovargasi p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT fernandezgalanma p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT moralesconejom p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT callegordomv p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT vitoriaminanai p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT correchermedinap p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT madinaveitiaochoaa p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT hernandezrivasja p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT garciafradej p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT ibarretxegerediagad p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT delgadomateosf p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT tormodiazmdm p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT ruizguinaldoma p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT moracasterae p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT noyapereirams p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT albarracinarraigosaa p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT lopezduplam p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT balanzatmunozj p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT lozanoalmelaml p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT labbadiaf p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT andradecamposm p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject
AT giraldop p1541preliminaryresultsoftwoyearsfollowupoftype1gaucherdiseasepatientstreatedwitheliglustatintrazelgaproject